HSCS
Income statement / Annual
Last year (2024), Heart Test Laboratories, Inc.'s total revenue was $18,600.00,
an increase of 261.17% from the previous year.
In 2024, Heart Test Laboratories, Inc.'s net income was -$6.61 M.
See Heart Test Laboratories, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
04/30/2024 |
04/30/2023 |
04/30/2022 |
04/30/2021 |
04/30/2020 |
| Operating Revenue |
$18,600.00
|
$5,150.00
|
$14,373.00
|
$25,604.00
|
$64,182.00
|
| Cost of Revenue |
$6,081.00 |
$2,796.00 |
$7,890.00 |
$10,665.00 |
$46,460.00 |
| Gross Profit |
$12,519.00 |
$2,354.00 |
$6,483.00 |
$14,939.00 |
$17,722.00 |
| Gross Profit Ratio |
0.67 |
0.46 |
0.45 |
0.58 |
0.28 |
| Research and Development
Expenses |
$2.88 M
|
$2.46 M
|
$3.00 M
|
$1.71 M
|
$2.04 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$3.44 M
|
$3.65 M
|
$1.71 M
|
$874,620.00
|
$1.80 M
|
| Other Expenses |
$0.00 |
$1,848.00 |
$2,558.00 |
-$3,451.00 |
$19,893.00 |
| Operating Expenses |
$6.32 M |
$6.12 M |
$4.72 M |
$2.58 M |
$3.84 M |
| Cost And Expenses |
$6.32 M |
$6.12 M |
$4.72 M |
$2.59 M |
$3.88 M |
| Interest Income |
$0.00 |
$243,174.00 |
$371,619.00 |
$132,454.00 |
$2,811.00 |
| Interest Expense |
$354,080.00 |
$243,174.00 |
$371,619.00 |
$132,454.00 |
$2,811.00 |
| Depreciation &
Amortization |
$95,133.00
|
$26,915.00
|
$26,566.00
|
$33,611.00
|
$63,826.00
|
| EBITDA |
-$6.16 M
|
-$6.08 M
|
-$4.43 M
|
-$2.29 M
|
-$3.74 M
|
| EBITDA Ratio |
-330.97 |
-1181.4 |
-325.63 |
-99.12 |
-58.19 |
| Operating Income Ratio
|
-339.02
|
-1186.98
|
-327.66
|
-100.3
|
-59.49
|
| Total Other
Income/Expenses Net |
-$299,438.00
|
-$241,326.00
|
-$118,861.00
|
$115,958.00
|
$7,066.00
|
| Income Before Tax |
-$6.61 M |
-$6.35 M |
-$4.83 M |
-$2.45 M |
-$3.81 M |
| Income Before Tax Ratio
|
-355.12
|
-1233.84
|
-335.93
|
-95.77
|
-59.38
|
| Income Tax Expense |
$0.00 |
$484.50 M |
-$250,200.00 |
$129,003.00 |
$22,704.00 |
| Net Income |
-$6.61 M |
-$490.85 M |
-$4.58 M |
-$2.58 M |
-$3.83 M |
| Net Income Ratio |
-355.12 |
-95311.51 |
-318.52 |
-100.81 |
-59.73 |
| EPS |
-18.74 |
-6173.88 |
-137.94 |
-77.89 |
-115.69 |
| EPS Diluted |
-18.74 |
-6173.88 |
-137.94 |
-77.89 |
-115.69 |
| Weighted Average Shares
Out |
$352,520.00
|
$79,505.00
|
$33,189.00
|
$33,138.00
|
$33,138.00
|
| Weighted Average Shares
Out Diluted |
$352,520.00
|
$79,505.00
|
$33,189.00
|
$33,138.00
|
$33,138.00
|
| Link |
|
|
|
|
|
